Cargando…
Current status of beta‐thalassemia and its treatment strategies
BACKGROUND: Thalassemia is an inherited hematological disorder categorized by a decrease or absence of one or more of the globin chains synthesis. Beta‐thalassemia is caused by one or more mutations in the beta‐globin gene. The absence or reduced amount of beta‐globin chains causes ineffective eryth...
Autores principales: | Ali, Shaukat, Mumtaz, Shumaila, Shakir, Hafiz Abdullah, Khan, Muhammad, Tahir, Hafiz Muhammad, Mumtaz, Samaira, Mughal, Tafail Akbar, Hassan, Ali, Kazmi, Syed Akif Raza, Sadia, Irfan, Muhammad, Khan, Muhammad Adeeb |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683628/ https://www.ncbi.nlm.nih.gov/pubmed/34738740 http://dx.doi.org/10.1002/mgg3.1788 |
Ejemplares similares
-
Advanced treatment strategies in breast cancer: A comprehensive mechanistic review
por: Mumtaz, Samaira, et al.
Publicado: (2023) -
Minocycline-Derived Silver Nanoparticles for Assessment of Their Antidiabetic Potential against Alloxan-Induced Diabetic Mice
por: Kazmi, Syed Akif Raza, et al.
Publicado: (2021) -
Apoptotic and antiproliferative effects of silk protein sericin conjugated-AgNO(3) nanoparticles in human breast cancer cells
por: Mumtaz, Samaira, et al.
Publicado: (2023) -
Hyaluronic acid-based nanofibers: Electrospun synthesis and their medical applications; recent developments and future perspective
por: Humaira,, et al.
Publicado: (2022) -
Peripheral Neuropathy in Beta-Thalassemia: Corneal Confocal Microscopy-Based Study
por: Khan, Saad A, et al.
Publicado: (2022)